Targeting Chromatin Effector Pygo2 to Enhance Immunotherapy in Prostate Cancer
Cited by 1
Related Papers
Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1
|Cell Metabolism|2023|199
Ketogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy
|Cancer Research|2024|56
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer
|Science Immunology|2023|29
UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells
|Scientific Reports|2020|27